Compare COLL & EVEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COLL | EVEX |
|---|---|---|
| Founded | 2002 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2015 | N/A |
| Metric | COLL | EVEX |
|---|---|---|
| Price | $37.27 | $2.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $50.83 | $6.88 |
| AVG Volume (30 Days) | 387.1K | ★ 929.5K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.73 | N/A |
| Revenue | ★ $780,567,000.00 | N/A |
| Revenue This Year | $6.07 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.55 | ★ N/A |
| Revenue Growth | ★ 23.62 | N/A |
| 52 Week Low | $23.23 | $2.83 |
| 52 Week High | $50.79 | $7.70 |
| Indicator | COLL | EVEX |
|---|---|---|
| Relative Strength Index (RSI) | 21.42 | 34.13 |
| Support Level | $34.30 | $2.86 |
| Resistance Level | $39.85 | $3.21 |
| Average True Range (ATR) | 1.61 | 0.17 |
| MACD | -0.83 | 0.04 |
| Stochastic Oscillator | 9.89 | 12.86 |
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment , a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.